Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Mottola Frank
SVP, Chief Tech. Ops. Officer at SUPERNUS PHARMACEUTICALS. Filing since 14 Mar 2023.
CIK 0001804567
Company
Date
Role
Action
Shares
Amount
Of holding
SUPN
SUPERNUS PHARMACEUTICALS, INC.
9 Mar 2026
SVP, Chief Tech. Ops. Officer
Sold at will
1,623
$87.07K
8.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
19 Dec 2025
SVP, Chief Tech. Ops. Officer
Sold on a plan
20,000
$1.01M
56.3%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
12 Sep 2025
SVP, Chief Tech. Ops. Officer
Sold at will
5,000
$229.35K
24.4%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
25 Aug 2025
SVP, Quality, GMP, Ops, IT
Sold at will
14,000
$623.14K
47.5%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
7 Nov 2024
SVP, Quality, GMP, Ops, IT
Sold at will
15,000
$554.70K
64.7%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
14 Nov 2023
SVP, Quality, GMP, Ops, IT
Sold at will
1,110
$31.22K
16.3%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
14 Mar 2023
Sr VP, Quality, GMP Oper. & IT
Sold, plan not stated
4,780
$172.02K
50.2%
7 decisions on file.